SCHEMBL6055083

SCHEMBL6055083

CN1CCN(S(=O)(=O)c2ccc(Cl)c([N+](=O)[O-])c2)CC1.CN1CCN(S(=O)(=O)c2ccc(NCc3ccccc3)c([N+](=O)[O-])c2)CC1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
VCAM1 P19320 3/20 0.69
PKM P14618 3/20 0.60
SMN1; SMN2 Q16637 2/20 0.60
LMNA P02545 4/20 0.60
TDP1 Q9NUW8 1/20 0.60
MAPT P10636 5/20 0.54
MEN1 O00255 1/20 0.54
KMT2A Q03164 1/20 0.54
SIRT6 Q8N6T7 1/20 0.54
L3MBTL1 Q9Y468 3/20 0.54
NPBWR1 P48145 1/20 0.53
MCHR1 Q99705 1/20 0.53
CYP1A2 P05177 1/20 0.51
CYP3A4 P08684 1/20 0.51
CYP2C9 P11712 1/20 0.51
CYP2C19 P33261 1/20 0.51
HTT P42858 1/20 0.51
ALDH1A1 P00352 1/20 0.51
NPSR1 Q6W5P4 1/20 0.51
GAA P10253 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL992901 0.95 PKM (0.66) VCAM1PKMSMN1; SMN2LMNATDP1
SCHEMBL992819 0.83 VCAM1 (1.00) VCAM1MEN1KMT2AL3MBTL1NPBWR1
SCHEMBL15468341 0.80 POLB (0.52) PKMSMN1; SMN2LMNATDP1MAPT
SCHEMBL1646176 0.79 POLB (0.51) PKMSMN1; SMN2LMNATDP1MAPT
SCHEMBL1844898 0.77 MAPT (0.72) PKMSMN1; SMN2LMNAMAPTMEN1
SCHEMBL3147203 0.77 SIRT6 (0.83) MAPTSIRT6L3MBTL1CYP1A2CYP3A4
SCHEMBL27870554 0.76 MAPT (0.52) PKMSMN1; SMN2LMNATDP1MAPT
SCHEMBL5951699 0.76 KMT2A (0.71) VCAM1PKMSMN1; SMN2LMNATDP1
SCHEMBL5479477 0.75 VCAM1 (0.63) VCAM1PKMSMN1; SMN2LMNATDP1
SCHEMBL1844134 0.74 MAPT (0.80) PKMSMN1; SMN2LMNAMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1648426-B1 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS PROTEIN KINASES INHIBITORS ASTEX THERAPEUTICS LTD (GB) 2014-01-08 EP disclosed
EP-1648426-A2 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS PROTEIN KINASES INHIBITORS Astex Therapeutics Limited (GB) 2006-04-26 EP disclosed
WO-2005002552-A2 BENZIMIDAZOLE DERIVATIVES AND THEIR USE AS PROTEIN KINASES INHIBITORS ASTEX THERAPEUTICS LIMITED (GB) 2005-01-13 WO disclosed